Although the key role of human homeobox (HOX) genes in development is well established, their function in adult cells is still under scrutiny. We have analyzed, in normal adult blood cell subpopulations, acute lymphoid leukemia (ALL) cell lines, and primary blasts, the RNA expression of all HOX-2 cluster genes (5'-2.5, 2. 4, 23, 22, 2.1, 2.6, 2-7, 2. 8, 29, 3') and nine genes in the HOX-I, -3, and -4 cluster by Northern blotting, RNAse protection, and/or reverse transcriptase polymerase chain reaction (RT-PCR). The analyzed HOX-I, -3, and -4 genes were never expressed in all tested cell populations. Natural killer (NK) cells activated in interleukin-2 (IL-2)/ IL-lptreated cultures exhibit a gradually increasing, abundant expression of three HOX-2 genes (2.2, 2.6, 2.8).
while three other genes (2.3, 2.1, 2 7 ) are expressed at a lower level at late culture times. However, no HOX-2 gens is expressed in quiescent lymphocytes (NK, B and T [T-cell receptor (TCR) a/ p, y/6 lymphocytes, thymocytes] cells),
HE HOMEOBOX (HOX) is a 183-bp sequence that
T was originally identified in a family of genes playing a key role in Drosophila embryonic Homeoproteins are localized in the nucleus, and represent trans-acting factors regulating gene expression. Indeed, the homeodomain binds to specific DNA sequences,6 which function as enhancers or silencers of transcription of target genes including HOX-containing Homeobox-containing genes are conserved in evolutionarily distant species, including mice and humans? In the human genome a cluster of at least nine HOX genes (HOX-2 locus) has been mapped on chromosome 17 (q11-q22),10-12 while HOX-1, -3, and -4 clusters are localized on chromosomes 7,12, and 2, re~pective1y.l~ The expression of HOX genes is stage-related, tissue-specific, and regionspecific in both mouse14-16 and human embryos.16-m In murine embryos inappropriate expression or targeted disruption of HOX genes causes a variety of malformations.21-2s Therefore, it is conceded that HOX genes play a key role in mammalian development, Although the role of HOXgenes in adult cell differentiation is still obscure, growing evidence suggests that they may play a key function in neoplastic blood cells, and particularly in acute myeloid leukemia (AML) Initial studies on a restricted number ofHOXgenes showed that in erythroleukemia and monocytic AML lines a few genes, mainly pertaining to the HOX-2 cluster, exhibit lineage-restricted expression, which is modulated during differentiation induced by chemical agent^?^,^^ More extensive investigations indicate that a variety of HOX genes in the HOX-I, -2, and -3 locus are expressed with different patterns and coordinately regulated in erythroleukemic, promyelocytic, and monocytic AML lines.% Gene transfer studies with 2.4 and/or interleukin-3 (IG3) suggest a combined role of HOXand growth factor genes in the leukemogenetic process.31 Finally, in a pre-B acute lymphoid leukemia (ALL) with t(1;19) translocation, a HOXfusion mRNA and protein may have a key pathogenetic f~nction.3~,~3 granulocytes, and monocytes. In B-and T-ALL cell lines, HOX-2 genes are expressed according to different patterns: (1) widespread transcription (seven of nine genes, including 2.3 and 2.6) in the Peer line bearing the TCR y/6; (2) expression of 2. 5, 2-2, and 2.6 in the SEZ 627 line, which derives from an HTLV-1+ T-helper leukemia; (3) transcription of 2 3 and 2.6 in both the T-ALL CEM line and four B-ALL lines (interestingly, CALLA-B-ALL lines are constantly 23/26 RNA+); (4) no HOX-2 gene expression was detected in one Tand two B-ALL lines. Primary blasts from five T-and five pre-B-ALL showed selective expression of one or more HOX-2 genes, namely 2.5, 2.2, 2. 6, and 2.7. Our data are compatible with the hypothesis that selected HOX-2 genes play a role in the IL-2/IL-l~nduced activation and/or proliferation of normal NK lymphocytes and possibly in the oncogenetic process of some T-and B-ALL. Q 1992 by The American Society of Hematology.
We have investigated the expression of all HOX-2 and nine HOX-1, -3, and -4 genes in purified cell populations from normal adult peripheral blood and in a variety of ALL cell lines and primary blasts. Our studies indicate expression of selected HOX-2 genes in both normal activated NK lymphocytes and a majority of T-and B-ALL.
MATERIALS AND METHODS

Natural Killer (NK) Cells Purification and Culture
Peripheral blood mononuclear cells (PBMC) were isolated by the standard Ficoll-Hypaque method. One hundred milliliters of heparinized blood was mixed with an equal volume of sterile Iscove's medium (IMDM, Flow, Irvine, UK). Thirty milliliters of diluted blood layered on 20 mL of Ficoll-Hypaque (Nyegaards, Oslo, Norway) in a sterile plastic tube was centrifuged at 35% for 40 minutes at 20°C. The bu@ coat was removed and the cells were washed three times with IMDM followed by centrifugation at 18% for 10 minutes.
PBMC were partially depleted of adherent cells (essentially monocytes) by two 1-hour incubation cycles in plastic culture flasks (Becton-Dickinson, Mountain View, CA). Cells were then sequentially depleted by a four-step procedure to sequentially remove CD14+ (residual monocytes), CD19+ (B lymphocytes), CD3+ (T lymphocytes), CD4+ (T-helper lymphocytes), and CD8+ (T- 
Primary Blasts From ALL
Samples of peripheral blood of ALL patients were obtained after informed consent. Leukemic blasts were isolated by centrifugation on a gradient of Ficoll-Hypaque under the above conditions.
The cushion of white blood cells, largely composed by leukemic blasts, was recovered and washed three times with RPMI-1640 medium. The cell pellet was stored in liquid nitrogen until analyzed. Primary blasts were classified according to FrenchAmerican-British (FAB) criteria and standard membrane immunologic markers. According to these criteria five ALL pertain to the T-cell lineage and five are of pre-B CALLA+ type? 4 The expression of HOX genes was investigated in several human leukemic lines pertaining to different hematopoietic lineages: T-cell leukemia (PEER, SEZ 627, CEM-CCRF, and TALL-1); B-cell leukemia (8392, SB-CCRF, GM1500, ALL 202, ALL1, ALL2B, and Daudi); erythroleukemia (K562); myeloblastic (KG1); promyelocytic (HL-60, AML-193, and MV4-11); monocytic (U-937 and AML-1).
Cell lines were grown under standard conditions in RPMI 1640 medium containing 10% fetal calf serum (FCS), with the exception of AML-193 cells that were grown in IMDM containing 10% FCS and 10 ng/mL rh granulomonocytic colony-stimulating factor (rhGM-CSF).
All cell lines were negative for mycoplasma. No lymphoid cell line was infected by lymphocytotropic viruses, with the exception of the SEZ 627 cell line that contains the HTLV-1 genome integrated into cellular DNA.35 KG1 was kindly provided by Dr G. Saglio (University of Turin, Italy); T-ALL-1, ALL 202, ALL 1, ALL 2B, AML 193, MV4-11, AML-1, and HMO cell lines were obtained from Dr G. Rovera (Wistar Institute, Philadelphia, PA); CEM-CCRF, 8392, SB-CCRF, and GM1500 lymphoid cell lines were purchased from American Tissue Culture Collection (Rockville, MD); U937 cell line was kindly provided by Dr K. Nilsson (University of Uppsala, Sweden); SEZ 627 cell line was kindly provided by Dr Tasuko Honjio (Kyoto University, Japan); finally, K562 cell line was obtained through the courtesy of Dr Carmen Lozzio (University of Tennessee, Knoxville).
Cell lines.
Analysis of Differentiation Markers in ALLILymphoma Cell Lines
Immunofluorescence experiments were performed using the following MoAbs: anti-HLA ABC (Dakopatt, Copenhagen, Denmark), anti-CALLA, -IgM, -IgD, -K, and -A chains (Technogenetics, Turin, Italy), anti-CD2, -CD3, -CD4, -CD7, -CD8, -CD19, -CD20, -CD22, -CR1, -CR2, -HLA-DR, -1L-2R a-chain (BectonDickinson), anti-IL-2R p-chain (TU-207) (courtesy of Dr Kazuo Sugamura, Department of Microbiology, Tohoku University, Sendai, Japan). Briefly, cells were washed three times at 4°C with Hanks' balanced saline solution and incubated (5 x 105) for 60 minutes at 4°C in the presence of an appropriate dilution of MoAb. After three washes with Hanks' solution, the cells were incubated 60 minutes at 4°C in the presence of fluorescein isothiocyanate (F1TC)-conjugated F(ab)'z sheep antimouse affinity-purified Igs (Technogenetics, Turin, Italy). After three additional washes in cold Hanks' solution, cells were resuspended in phosphatebuffered saline (PBS)-formaline and analyzed using a fluorescenceactivated cell sorter (FACScan, Becton-Dickinson).
Probes
The following probes were used for Northern blot analysis:
ii HueIII-HueIII, 300 bp; 2.4, HueIII-HaeIII, 600 bp; 2.3, HaeIII-HueIII, 500 bp; 2.2, ApuI-EcoRI, 300 bp; 2.1, PvuII-PvuII, 500 bp; 2.6, HindIII-HindIII, 300 bp; 2.7, EcoRIBgl 11,900 bp; 2.8, SmuI-SmuI, 100 bp (17); 2.9, PvuII-PvuII, 600 bp from the genomic clone BC20636: all of these probes are localized 3' to the HOXregion. HOX-I: 1.2, TaqI-TuqI, 700 bp containing part of the homeobox and its 3' region and 1.3, EcoRI-EcoRI, 3. In the RNAse protection analysis riboprobes synthesized from the following fragments were used: 2.2, 128 bp SmuI-XhoI, 40 
RNA Analysis by Northem Blotting, RNAse Protection, and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from cells by the standard guanidinium thiocyanate technique.
Northern bloning. Poly(A)+ was selected by one passage on oligo (dT)-cellulose columns.41 Four micrograms of poly(A)+ eluted from 200 kg of total RNA was run on 1.0% agaroseformaldehyde gels, transferred to nylon membranes (Hybond N, Amersham, Buckinghamshire, England) by capillary blotting, and hybridized to lo7 cpm DNA probe labeled by multiprime random priming to a specific activity of 3 to 4 x 10s dpm/kg.
Prehybridization and hybridization were performed as previously described.19 After stringent washing (15 mmol/L NaC1/1.5 mmol/L sodium citrate/O.l% NaDodS04 at 65°C) the blots were exposed for 3 to 7 days at -70°C to Kodak X-OMAT AR film (Eastman Kodak, Rochester, NY) in an X-omatic intensifying For personal use only. on January 14, 2018. by guest www.bloodjournal.org From HOX-2 GENES IN ALL AND NK CELLS 187 screen box. Probes were then removed by a solution consisting of 0.005 mol/L Tris-HC1 pH 8.0; 0.002 mol/L Naz EDTA, Ficoll 0.002%, polyvinyl pirrolidone 0.002%, bovine serum albumin 0.002%, at 65°C for 1 hour and the filters rehybridized. P-Actin probe was used for normalization.
RNA probes were synthesized to high specific activity from DNA fragments cloned in the pGEM4Z vector (Promega, Madison, WI) to generate 32P-labeled antisense RNAs according to standard protocols (Promega)." In each experiment, 20 pg of total RNA was hybridized to 2 x 105 cpm of each probe. Hybridization and RNAse digestion were performed according to standard procedures." Samples were run on an 8 mol/L urea/6% acrylamide gel. Gels were dried and exposed for 1 to 10 days to Kodak X-OMAT AR film in an X-omatic intensifying screen box.
RT-PCR. Twenty micrograms of total RNA was reversetranscribed into cDNA (MMLV-RT; BRL, Gaithersburg, MD) using 250 ng of oligo-dT as primer. An aliquot of each RT reaction was incubated in the presence of C X~~P -~C T P tracer and the reverse transcribed RNA/DNA was normalized accordingly. One microgram of reverse-transcribed mRNA was amplified for each sample. bp. 43 PCR was performed in a total volume of 100 FLL; 10 pL of each sample was separated in a 2% agarose gel and transferred to a nylon filter. Filters were hybridized with a probe end-labeled with y3*P-ATP and polynucleotide kinase. The same negative samples for HOX-2 gene expression (ie, T lymphocytes and monocytes) and a mock reaction were used for each RT-PCR experiment.
The levels of transcripts for each HOX-2 gene in various samples were semi-quantified by densitometer scanning with a laser densitometer (LKB) after normalization with pz-microglobulin. As mentioned above, an additional control was represented by normalization of the amount of the reverse-transcribed RNA/DNA.
DNA Analysis
High molecular weight DNA was extracted from 10s cells, digested with restriction endonucleases, electrophoresed in 1% RNAse protection.
S'GAACGTGCTTCITTGTAATGACCAAGGTACCGATTTC-
agarose gels, transferred onto nylon filters, and hybridized to 2 x lo7 cpm of radiolabeled probe as de~cribed.4~
RESULTS
We analyzed 10 ALL (4 pertaining to the T-and 6 to the B-cell lineage), 1 B lymphoma, and 7 AML cell lines (1 erythroid and 6 myelo-monocytic), as well as the primary blasts from 5 T-and 5 pre-B-ALL."
HOX gene expression was also investigated in purified populations of normal peripheral blood cells (granulocytes, monocytes, T, B, and NK lymphocytes) and thymocytes, as well as in IL-2/IL-l&stimulated NK cells.
Eqression of HOX Genes in ALL Cell Lines
Genes pertaining to the HOX-2 cluster are widely expressed in human ALL cell lines as evaluated by Northern blotting of poly(A)+ RNA ( Table 1) . Four patterns were observed: (1) transcription of seven HOX-2 genes in the Peer T-ALL line; (2) In Peer cells (Fig lA) , the size of HOX-2 transcripts is comparable to that observed in normal human embryos,17 with the exception of 2.2, which shows a 1.3-kb band in addition to the 1.6-kb mRNA, probably representing the alternative transcript previously reportedm and 2.8 expressing two distinct transcripts of 1.7 and 1.5 kb, respectively. Because Northern blot was performed in a strictly standardized fashion, the level of expression of HOX-2 genes may be evaluated on a roughly quantitative basis. In this regard, we noted that the 2.5 and 2.3 mRNA is particularly abundant. Figure 1B shows the Northern blot of HOX-2 RNAs expressed in SEZ 627 cells. The size of the 2.6 mRNA is similar to that described in human embryos.17 The faint 2.5 transcripts comprise both the 3.4-kb mRNA17 and an undescribed smaller band; similarly, 2.2 is transcribed in two RNA species, one of which is smaller than the 1.6-kb mRNA, as also observed in Peer cells. For personal use only. on January 14, 2018. by guest www.bloodjournal.org 1.4, 1.3, 1.2 (HOX-I), 3.3,3.4,3.5 (HOX-3) or  4.2, 4.4, 4.5 (HOX-4) was detected by poly (A)+ RNA Northern blot analysis.
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expression, which was analyzed by RNAse protection).
the presence of inverted repeats in its sequence, the expression of this gene was analyzed by RNAse protection (data not shown). Of the five T-ALL, all were positive for 2.5, three for 2.2, and three for 2.7. In regard to pre-B ALL, 315 were positive for 2.5, 315 for 2.2, 314 for 2.6, and 315 for 2.7. One, two, three or four HOX genes were expressed in each sample. Cluster genes 2.4, 2.3, 2.1, and 2.8 were never expressed in the analyzed leukemias. The expression levels of HOX-2 genes in primary ALL blasts were variable, ranging from 5% to 73% as compared with the levels observed in the Peer line. as evaluated bv densitometer 
Expression of HOX-2 Genes in Primary ALL Blasts
We screened five T-and five pre-B-ALL by RT-PCR for HOX-2 genes (Table 3 and Fig 3) . Because RT-PCR analysis of 2.6 mRNA was unsatisfactory, possibly due to represents the mean value from three separate experiments.
scanning of the autoradiographs, after normalization with pz-microglobulin.
Erpresson of HOX-2 Genes in Normal Adult Blood Cells
Northern blot and RT-PCR analysis of HOX-2 genes (as well as RNAse protection assay of 2.6, see above) showed that these genes are not expressed in resting T lymphocytes (expressing TCR alp or y l h as well as thymocytes), CD3-NK, B lymphocytes, granulocytes, and monocytes (data not shown).
Expresson of HOX-2 Genes in IL-2/IL-l&stimuhted NK Cel LF
CD3-purified NK cells were grown in tke presence of IGlg (25 ng1mL) and IL2 (1@ UImL). Under these culture conditions, NK cells display from day 3 to 4 a clear increase of their antitumor cytotoxic activity (as evaluated by their capacity to lyse NK-resistant tumor cell lines); from day 4 they initiate DNA synthesis (as indicated by 3H-thymidine incorporation), while an increase of their number is monitored from day 7 (data not shown).
CD3-NK cells activated and induced to proliferate by IL-lp and IL2 for 9 to 24 days showed a gradually increasing transcription of 2.2, 2.6, and 2.8, as indicated by Northern blot analysis of poly (A)+ RNA (results not shown). In a second series of experiments, RNAse protection analysis confirmed that 2.2,2.6, and 2.8 are transcribed in 9-to 24-day activated NK cells at a level comparable with that of the Peer cell line (Fig 4A) . The level of 2.2, 2.6, and Finally, RT-PCR analysis indicated a low level of expression of 2.3, 2.1, and 2.7 in 24-day activated NK cells, while no expression was detected in 9-day cultures (Fig 4B) .
DISCUSSION
Previous studies have analyzed the expression of HOX genes in human AML cell lines pertaining to the erythroid and granulo-monocytic lineage.wM Our results provide evidence for a broad and complex pattern of expression of HOX-2 genes in human neoplastic lymphocytes. Indeed, (1) a high proportion (four of six) of B-ALL lines express both 2.3 and 2.6, whereas no HOX-2 gene is transcribed in normal circulating B lymphocytes; (2) three of four T-ALL cell lines express several genes of the HOX-2 cluster (ie, the Peer line expresses all HOX-2 genes except 2.4 and 2.9, the SEZ line only 2.2, 2.5,2.6, the CEM line both 2.3 and 2.6), whereas quiescent T lymphocytes from adult peripheral blood or thymus did not show transcription of HOX-2 genes. Moreover, 1.4, 1.3, 1.2,  (HOX-I),3.3, 3.4, 3.5, (HOX-3) and 4.2, 4.4, 4.5, (HOX-4) genes were not expressed in any of the above-mentioned lymphoid cell populations, thus suggesting the specificity of HOX-2 gene expression.
Conversely, HOX-2 genes are occasionally expressed in Our studies on primary ALL blasts indicate that 2.5,2.2, 2.6, and 2.7, but not 2.4,2.3,2.1, and 2.8 are expressed in Tand pre-B-ALL. The pattern of HOX-2 expression in primary ALL blasts is variable, in that these A L L exhibit transcription of one, two, three, or four of these genes.
Normal cells from adult peripheral blood (ie, TCR alp or y/6 T cells, thymocytes, B lymphocytes, CD3-NK cells, granulocytes, and monocytes) do not express any of the HOX-2 genes.
Interestingly, CD3-activated NK cells grown in I L Z / I L 1s-supplemented culture transcribe 2.2, 2.6, and 2.8 at a gradually increasing, abundant level, while 2.3, 2.1, and 2.7 are expressed at low level and late culture times. The transcription of HOX-2 genes in activated NK cells may be linked to their proliferative status and/or acquisition of new functional properties (ie, induction of LAK antitumor cytotoxic activity). The kinetics of HOX-2 gene expression is compatible with a role in NK proliferation control. On the other hand, the LAK activity is monitored before the onset of significant HOX-2 gene expression, thus rendering unlikely a role of HOX-2 genes in this phenomenon.
Our preliminary data further indicate that activated TCR alp or y/6 T lymphocytes express a variety of HOX-2 genes (results not shown here). In this regard, 2.3 expression has been linked to the activation of T and B lymphocytes.5152 Therefore, we suggest that selected HOX-2 genes may play a role in the proliferation of normal NK and T cells.
In conclusion, these studies indicate the specific expression of a variety of HOX-2 genes in a majority of T-and B-ALL cell lines and primary blasts, as well as in activated NK cells. These findings may reflect an important functional role of selected HOX-2 genes in these cell populations, via interaction of the corresponding homeoproteins with target genes. Because HOX genes are considered to play a key role in the early development of a variety of mammalian tissues and body part^'^,^-^ they may be involved in the control of the proliferation/differentiation of restricted populations of adult cells (eg, NK and T lymphocytes). Moreover, growing evidence supports a role for mammalian HOX genes as cofactors in myeloid/ lymphoid le~kemogenesis3~J3: therefore, it is also suggested that the expression of selected HOX-2 genes in B-and T-ALL may represent a significant oncogenetic cofactor.
NOTE ADDED IN PROOF
After submission of this manuscript, C.H.E. Mathews et a1 (Blood 78:2248,1991) reported expression of a majority of HOX-2 genes in erythroleukemic lines, as well as transcription of 2.6 and often 2.3 in B/T lymphoid leukemic lines, which did not include the Peer and SEZ lines.
